Drug trafficking in Europe changes as expertise in synthetic drug production increasesBMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f758 (Published 06 February 2013) Cite this as: BMJ 2013;346:f758
- Rory Watson
Europe’s illicit drugs trade is entering a new era, forcing policy makers to rethink their responses, says a report commissioned by Cecilia Malmström, the European commissioner for home affairs.1
Historically, the illicit drug market in Europe centred on specific drugs trafficked by specialised operators along well defined routes. Now experts note that the market is far more fluid as new routes and multi-substance consignments become more common.
Commenting on the findings, Malmström said, “Drug markets are evolving, and we need …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial